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Abstract
Purpose:  To  provide  quantitative  information  on  emphysema  in  asymptomatic  smokers  in  cor-
relation with  pulmonary  function  tests  (PFT).
Patients  and  methods:  The  study  population  included  75  smokers  (current  smokers:  n  =  39;  ex-
smokers:  n  =  36)  and  25  nonsmokers  who  underwent  volumetric  high-resolution  CT  of  the  chest
with automated  quantiﬁcation  of  emphysema  and  PFTs.
Results:  Current  smokers  had  a  higher  percentage  of  emphysema  in  the  right  lung  (P  =  0.041)
and right  upper  lobe  (P  =  0.037).  The  overall  percentage  of  emphysema  did  not  differ  according
to the  Gold  stage  (P  =  0.77).  Smokers  with  emphysema  had  signiﬁcantly  higher  mean  values  of
FRC (P  =  0.012),  RV  (  <  0.0001)  and  TLC  (P  =  0.0157)  than  smokers  without  emphysema  but  no
signiﬁcant  differences  were  found  in  neither  the  mean  values  of  TLCO  nor  in  expiratory  ﬂows
(P >  0.05).  Correlations  were  found  between  the  percentage  of  emphysema  and  (a)  cigarette
consumption  of  current  (r  =  0.34215;  P  =  0.0330)  and  ex-smokers  (r  =  0.44104;  P  =  0.0071);  and
(b) alterations  of  TLC,  FRC,  RV  and  DLCO  of  smokers.
Conclusion:  Quantitative  CT  allo
tional alterations  in  smokers  wit
© 2013  Published  by  Elsevier  Ma
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igarette  smoking  is  a  major  factor  associated  with  the
evelopment  of  emphysema.  Recently,  it  has  also  been  rec-
gnized  as  an  independent  risk  factor  for  lung  cancer  [1—3].
ecause  of  the  poor  prognosis  of  both  conditions,  there
re  obvious  medical  and  economical  reasons  justifying  the
etection  of  subclinical  abnormalities  in  smokers  in  order
o  reinforce  prevention  and  intensify  smoking  cessation
ampaigns.  Whereas  some  functional  proﬁles  can  suggest
he  presence  of  emphysema,  high-resolution  CT  (HRCT)  is
n  established  tool  for  the  in  vivo  assessment  of  emphy-
ema,  mainly  used  to  investigate  populations  with  advanced
ung  disease  [4,5].  Because  emphysema  has  a  long  and
ilent  evolution,  it  would  be  clinically  relevant  to  detect
he  disease  when  lung  destruction  is  limited  and  effec-
ive  prevention  of  functional  impairment  can  be  expected
rom  smoking  cessation  programs.  To  date,  CT  has  been
ainly  used  to  describe  the  prevalence  of  emphysema  in
symptomatic  smokers  using  sequential  scanning  [6—12].
owever,  the  severity  of  lung  destruction  was  only  subjec-
ively  assessed,  a  methodological  approach  known  to  be
imited  by  several  drawbacks,  including  systematic  over-
stimation  and  moderate  interobserver  agreement  [13,14].
ith  the  advent  of  early  lung  cancer  detection  trials,  low-
ose  volumetric  CT  has  become  the  reference-imaging  tool
or  detection  and  quantiﬁcation  of  emphysema  in  popu-
ations  mainly  composed  of  heavy  smokers  with  extensive
mphysema  and  altered  pulmonary  functions  tests  [15—17].
he  purpose  of  the  present  study  was  to  investigate  a
ohort  of  asymptomatic  smokers  without  airﬂow  obstruc-
ion  to  determine  whether  quantitative  CT  ﬁndings  could  be
orrelated  to  functional  changes  in  this  speciﬁc  subset  of
mokers.
aterials and methods
opulation
his  investigation  was  approved  by  the  local  ethics  com-
ittee,  and  written  informed  consent  was  obtained  from
ll  subjects.  Our  study  group  was  drawn  from  a  popu-
ation  of  250  asymptomatic  hospital  workers,  recruited
or  evaluation  of  tobacco-related  small  airways  disease
n  2001  [18]  who  joined  the  programme  of  longitudi-
al  evaluation  of  healthy  smoker’s  lung  developed  in  our
nstitution  [6,7].  In  2007,  this  population  was  invited  to
articipate  in  a  follow-up  evaluation,  which  comprised  a
linical  examination,  pulmonary  function  tests  (PFTs)  and
 volumetric  CT  examination,  all  performed  within  three
eeks  after  inclusion.  From  the  baseline  study  group,
50  subjects  could  not  be  included  for  the  following  rea-
ons:
84  subjects  were  unable  to  respond  because  of  retire-
ment,  invalidity,  job  cessation,  or  because  they  had  move
to  another  city;
13 patients  declined  the  follow-up  evaluation;
5 subjects  had  died;
15  subjects  had  undergone  only  part  of  the  investigations
(either  CT  or  PFTs);
O
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quantitative  analysis  of  CT  scans  was  not  achievable  for  28
subjects  whose  raw  data  had  become  inaccessible  (i.e.,
altered  external  disks);
5 subjects  could  no  longer  be  considered  as  ‘‘healthy’’
smokers  because  of  development  of  severe  dyspnea
and/or  alterations  in  pulmonary  function  tests  (Gold  2
stage:  n  =  3;  Gold  3:  n  =  2).
Our  ﬁnal  study  group  of  100  subjects  included  75  asymp-
omatic  smokers  (39  current  smokers  [subjects  who  had
moked  regularly  for  more  than  5  years];  36  ex-smokers  [sub-
ects  who  had  not  smoked  for  more  than  2  years])  and  25
onsmokers.
T evaluation
cquisition  parameters
he  CT  protocol  consisted  of  noncontrast  volumetric
xaminations  over  the  entire  thorax  with  64-slice  MDCT
Deﬁnition,  Siemens  Medical  Solutions,  Germany),  obtained
t  deep  inspiration.  The  examinations  were  obtained  with
he  patients  scanned  in  the  supine  position,  using  the  fol-
owing  parameters:  100  to  120  kVp;  collimation:  32  ×  0.6  mm
ith  z-ﬂying  focal  spot  for  the  simultaneous  acquisition  of
4  overlapping  0.6  mm  slices;  rotation  time:  0.33  s;  pitch:
.2  to  1.5.  The  examinations  were  systematically  obtained
ith  4D  dose  modulation  (Care  Dose  4D;  Siemens  Medical
olutions).  Following  the  manufacturer’s  recommendations,
e  carefully  checked  the  calibration  of  our  equipment  (cali-
ration  in  the  air  on  a  daily  basis;  water  phantom  tests  every
 months).
mage  reconstruction
olumetric  data  sets  led  to  the  reconstruction  of  contiguous
-mm  thick  images.  Lung  images  were  reconstructed  using
 high-spatial-frequency  algorithm  (B50)  and  photographed
t  standard  (window  width,  1600  HU;  window  centre,  —600
U)  and  narrow  (window  width,  1000  HU;  window  cen-
re,  —800  HU)  window  settings.  These  images  were  used
or  morphological  analysis.  Quantitative  analysis  of  emphy-
ema  was  obtained  using  the  images  reconstructed  with  the
oft  reconstruction  kernel  (B20)  (Appendix  I).  Analysis  of  CT
mages  was  systematically  obtained  on  a  clinical  workstation
MMWP;  Siemens  Health  care,  Forchheim,  Germany).
T  parameters  analyzed
canning  conditions
e  systematically  recorded  the  duration  of  data  acquisi-
ion,  z-axis  coverage,  patient  radiation  dose,  using  the  dose
ength  product  (DLP)  in  mGy  cm  calculated  by  the  CT  com-
uter.  On  lung  inspiratory  scans,  we  recorded  the  presence
f  cardiac  and/or  respiratory  motion  artifacts,  rated  as
bsent  (score  0),  minimal  (score  1),  moderate  (score  2)  or
evere  (score  3)  to  provide  information  on  the  overall  quality
f  lung  images.
orphologic  assessment  of  emphysema
n  volumetric  lung  images,  we  visually  assessed  the  pres-
nce  of  emphysema  using  the  morphological  criteria  deﬁned
y  the  Fleischner  Society  [19]  (i.e.  centrilobular,  paraseptal
nd  panlobular  emphysema).
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Quantiﬁcation  of  emphysema
An  automated  quantiﬁcation  of  lung  volumes  and  emphy-
sema  was  obtained  using  a  dedicated  software  after
exclusion  of  artifacts  mimicking  emphysematous  lesions,  as
described  in  the  Appendix  I  section.
Conditions  of  image  analysis
Each  examination  was  successively  viewed  by  two  readers
(KY,  a  junior  reader  with  3  years  of  experience  in  read-
ing  CT  scans;  and  MRJ,  a  senior  chest  radiologist  with  20
years  of  experience  in  chest  CT  imaging),  the  senior  reader
conﬁrming  the  presence  or  absence  of  emphysema  on  each
examination.  This  analysis  was  undertaken  without  informa-
tion  on  the  subject’s  clinical  status.  When  emphysema  was
visually  depicted,  the  two  readers  undertook  its  objective
quantiﬁcation  after  exclusion  of  pseudo-emphysematous
artifacts  by  consensus.
Pulmonary function evaluation
All  subjects  had  PFTs  performed  on  a  body  plethysmograph
(Matserscreen  Body,  Viasys  Health  care,  Jaeger,  Hoech-
berg,  Germany)  according  to  the  guidelines  of  the  European
Respiratory  Society  [20]  and  supervised  by  two  seniors  inves-
tigators  (NCK;  JLE).  PFTs  were  obtained  on  the  same  day
as  CT  scanning.  Three  reproducible  maximum  expiratory
ﬂow-volume  curves  were  obtained  for  all  subjects.  The  fol-
lowing  parameters  were  recorded:  the  forced  vital  capacity
(FVC);  the  forced  expiratory  volume  in  one  second  (FEV1);
the  ratio  of  FEV1  to  VC  (FEV1/FVC);  the  maximal  mid  expira-
tory  ﬂow  (MMEF),  the  maximal  expiratory  ﬂow  (MEF)  at  75%,
50%  and  25%  of  FVC.  The  mean  values  of  total  lung  capacity
(TLC),  residual  volume  (RV)  and  functional  residual  capac-
ity  (FRC)  were  calculated  from  the  three  plethysmographic
measurements.  The  carbon  monoxide  transfer  factor  (TLCO)
was  measured  with  the  single-breath  method.  Lung  status
was  deﬁned  based  on  American  Thoracic  Society  Gold  crite-
ria  for  characterizing  COPD  derived  from  spirometry-based
FEV1/FVC  measures  [21].  The  Gold  stages  were  as  follows:
• stage  I (mild  COPD):  FEV1/FVC  <  0.70;  FEV1  ≥  80%  pre-
dicted;
• stage  II  (moderate  COPD):  FEV1/FVC  <  0.70;  50%
≤  FEV1  <  80%  predicted;
• stage  III  (severe  COPD):  FEV1/FVC  <  0.70;  30%
≤  FEV1  <  50%  predicted;
• stage  IV  (very  severe  COPD):  FEV1/FVC  <  0.70;  FEV1  <  30%
predicted  or  FEV1  <  50%  predicted  plus  chronic  respiratory
failure.
In  this  study,  we  used  the  ex-terminology  of  ‘‘Gold  stage
0’’  to  describe  subjects  with  normal  PFTs,  namely  FEV1/VC
≥  70%  and  FEV1  ≥  80%  predicted  [22],  whether  presenting  as
asymptomatic  subjects  or  subjects  with  symptoms  of  chronic
bronchitis.
Statistical analysis
Statistical  analysis  was  performed  with  commercially  avail-
able  software  (SAS  Institute,  Cary,  N.C.  25513;  version
9.1).  Results  were  expressed  as  means,  standard  deviations,
median  and  range  for  continuous  variables  and  as  frequen-
cies  and  percentages  for  categorical  variables.  Comparative s611
nalyses  were  obtained  using  the  chi-square  test  for  cate-
orical  data.  For  numerical  variables,  comparative  analyses
etween  the  three  groups  (current  smokers;  ex-smokers;
onsmokers)  were  performed  using  a  Kruskal—Wallis  test.
e  used  a Mann—Whitney  test  with  a  Bonferroni  cor-
ection  for  the  post  hoc  analysis.  For  comparison  of
ubgroups  (current  smokers  with  emphysema  vs  ex-smokers
ith  emphysema;  or  smokers  with  emphysema  vs  smok-
rs  without  emphysema),  we  used  a  Mann-Whitney  test.
he  relationships  between  the  numerical  variables  were
ssessed  and  tested  using  the  Pearson  correlation  coefﬁ-
ient.
esults
opulation characteristics
he  study  population  comprised  75  smokers  (39  current
mokers;  36  ex-smokers)  and  25  nonsmokers.  As  shown  in
able  1,  there  was  no  statistically  signiﬁcant  difference
etween  the  three  subgroups  except  for  the  BMI  (P  =  0.0094).
lthough  the  PFT  results  were  within  the  normal  range
Table  2),  we  observed  statistically  signiﬁcant  differences:
between  current  smokers  and  ex-smokers  for  the  median
values  of  FEV1/FVC  (P  =  0.0382),  MEF  25-75  (P  =  0.0469),
FRC  (P  =  0.0133)  and  TLCO  (P  =  0.0013);
between  current  smokers  and  nonsmokers  for  the  median
value  of  RV  (P  =  0.0329).
According  to  the  Gold  criteria,  there  were  65  smokers
t  Gold  stage  0  (current  smokers:  n  =  31;  ex-smokers:  n  =  34)
nd  10  smokers  at  Gold  stage  1  (current  smokers:  n  =  8;  ex-
mokers:  n  =  2).
canning conditions
he  mean  (±  SD)  height  of  the  volume  scanned  was
26.8  ±  38.56  mm;  the  mean  (±  SD)  duration  of  data  acqui-
ition  was  3.75  (±  0.44)  s;  the  mean  (±  SD)  DLP  was
83.2  ±  70.19  mGy  cm.  The  overall  quality  of  lung  images
as  deemed  acceptable  for  depiction  of  emphysematous
hanges  despite  the  presence  of:
respiratory  motion  artifacts  in  the  lower  lung  zones  of  31
examinations  (mild:  n  =  30;  moderate:  n  =  1);
cardiac  motion  artifacts  around  the  mediastinal  car-
diovascular  structures  in  79  examinations  (mild:  n  =  77;
moderate:  n  =  2).
There  was  no  statistically  signiﬁcant  difference  in  the  fre-
uency  of  respiratory  and  cardiac  motion  artifacts  between
urrent  smokers,  ex-smokers  and  nonsmokers  (P  >  0.05).
T assessment of emphysema
here  were  statistically  signiﬁcant  differences  concerning:
the  frequency  of  emphysema  between  current  smokers
(n  =  21;  53.85%)  and  ex-smokers  (n  =  8;  22.22%)  (P  =  0.005);
between  current  smokers  (n  =  21;  53.85%)  and  nonsmokers
(n  =  1;  4%)  (P  <  0.0001).
The  vertical  distribution  of  emphysema  in  smokers
howed  emphysematous  changes  in  the  upper  lobes  (n  =  26),
612  K.  Yasunaga  et  al.
Table  1  Characteristics  of  the  population  studied.
Current
smokers
n  =  39
Ex-smokers
n  =  36
Nonsmokers
n =  25
P  value
Sex  ratio  (males/females)  16/23  20/16  9/16  0.2608a
Age,  year
mean  ±  SD  48.5  ±  5.92  50.4  ±  5.99  50.6  ±  6.42  0.2680b
median,  range  48  [34—59]  49.5  [41—64]  51  [35—65]
Tobacco  consumption,  pack-year
mean  ±  SD 25.8  ±  14.72 24.4  ±  20.68 0 —
median,  range 26  [1—70] 20  [0.5—90]
BMI,  kg/m2
mean  ±  SD  25.1  ±  4.03  28  ±  4.92  24.9  ±  4.34  0.0094b
median,  range  24.2  [19.3—39.8]  26.6  [19.7—41.5]  24.5  [16.6—32.8]
BMI: Body mass index.
a refers to comparisons using the chi-square test.
b refers to comparisons using the Kruskal—Wallis test.
Table  2  Pulmonary  function  test  results  in  the  studied  population.
Current  smokers
n  =  39
Ex-smokers
n =  36
Nonsmokers
n  =  25
P  value
FVC,  %  pred
mean  ±  SD  112.6  ±  14.2  108.5  ±  14.5  113.0  ±  16.4  0.3824
median,  range  111.4  [89.5—138]  107.7  [81.2—135.7]  114.4  [79—150.2]
FEV1,  %  pred
mean  ±  SD  99.9  ±  12.6  101.5  ±  12.8  104.2  ±  14.6  0.5471
median,  range  98.1  [78.5—131.9]  100.9  [71.5—129.1]  102.7  [79.2—136.8]
FEV1/VC,  %  pred
mean  ±  SD  94.3  ±  7.4  98.6  ±  6.2  98.1  ±  5.7  0.0428
median,  range  93.9  [72.7—107.9]  98.2  [85.7—110]  98.2  [87.2—110]
MMEF,  %  pred
mean  ±  SD  72.8  ±  22.9  85.9  ±  22.7  85.9  ±  23.8  0.0386
median,  range  70.2  [30.2—119.3]  82.7  [46.4—132.7]  82  [45.6—136.1]
TLC,  %  pred
mean  ±  SD  107.4  ±  12.1  101.2  ±  12.1  103.2  ±  12.4  0.1675
median,  range  106.6  [77.7—140.5]  103.4  [76.2—124.6]  105.3  [73.9—134.7]
FRC,  %  pred
mean  ±  SD  104.4  ±  19.9  92  ±  17.9  95.1  ±  22.6  0.0169
median,  range  103.2  [49.9—140.3]  90.4  [56.2—127.9]  91.2  [66.2—146.3]
RV,  %  pred
mean  ±  SD  110.9  ±  23.3  100.7  ±  18.7  96.8  ±  18.8  0.0414
median,  range  113  [58.3—161.5]  103.9  [57.2—139.7]  94.7  [64—131.1]
TLCO,  %  pred
mean  ±  SD  78.5  ±  12  87.7  ±  11  86.9  ±  14.9  0.0021
median,  range  77.3  [45—111.2]  85.3  [68—111.8]  82.2  [67.4—130.2]
% pred: Percentage of predicted values; SD: Standard deviation; FVC: Forced vital capacity; FRC: Functional residual capacity; FVC:
Forced vital capacity; MMEF: Maximal mid expiratory ﬂow; FEV1: Forced expiratory volume in one second; VC: Vital capacity; TLCO:
Carbon monoxide diffusing capacity; RV: Residual volume; TLC: Total lung capacity
Test results are expressed as measured to predicted ratios and are presented as means ± SDs, medians and ranges. Statistical analyses
were obtained using the Kruskall—Wallis test. Signiﬁcant differences between the three groups are underlined in bold characters.
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right  middle  lobe  and/or  lingula  (n  =  10)  and  lower  lobes
(n  =  14)  with  an  exclusive  or  predominant  distribution  of
emphysema  in  the  upper  lobes  in  23  smokers  (23/29;  79%).
Emphysema  was  bilateral  in  21  smokers  and  unilateral  (right-
sided)  in  eight  smokers.
Table  3  summarizes  quantitative  information  on  emphy-
sematous  changes  in  smokers’  lungs.  There  was  no
statistically  signiﬁcant  difference  in  the  overall  percentage
and  regional  distribution  of  emphysema  between  current
smokers  and  ex-smokers.  Considering  the  29  current  and
ex-smokers  with  emphysema  altogether:
• the  percentage  of  emphysema  was  signiﬁcantly  higher  in
the  upper  lobes  compared  to  the  lower  lobes  (RUL  vs  RLL:
P  =  0.009;  LUL  vs  LLL:  P  =  0.017);• the  percentage  of  emphysema  did  not  differ  between  the
right  and  left  upper  lobes  (P  =  0.147)  nor  between  the  right
and  left  lower  lobes  (P  =  0.7549);
t
v
a
Table  3  Percentage  of  emphysema  on  lung  images  of  smoker
Smokers  wit
emphysema
n =  29
Overall  %  of  emphysema
mean  ±  SD  0.35  ±  1.04  
median,  range  0.02  [0—5.1
%  of  emphysema  in  the  right  lung
mean  ±  SD  0.24  ±  0.53  
median,  range  0.03  [0—2.1
%  of  emphysema  in  the  left  lung
mean  ±  SD  0.46  ±  1.63  
median,  range  0.01  [0—8.3
%  of  emphysema  in  the  right  upper  lobe  (RUL)
mean  ±  SD  0.41  ±  0.  84
median,  range  0.07  [0—3.8
%  of  emphysema  in  the  left  upper  lobe  (LUL)
(culmen  &  lingula)
mean  ±  SD  0.52  ±  1.58  
median,  range  0.03  [0—7.0
%  of  emphysema  in  the  right  middle  lobe  (RML)
mean  ±  SD  0.06  ±  0.20  
median,  range  0  [0—1.05]  
%  of  emphysema  in  the  right  upper  and  right
middle  lobe  (RUL  +  RML)
mean  ±  SD  0.46  ±  0.94  
median,  range  0.08  [0—3.8
%  of  emphysema  in  the  right  lower  lobe  (RLL)
mean  ±  SD  0.13  ±  0.51  
median,  range  0  [0—2.71]  
%  of  emphysema  in  the  left  lower  lobe  (LLL)
mean  ±  SD  0.35  ±  1.72  
median,  range  0  [0—9.29]  
%: percentage. Statistical comparisons between current smokers and ex-
test.613
however,  when  comparing  the  extent  of  emphysema  in
the  right  upper  and  middle  lobes  versus  the  left  upper
lobe  (i.e.  culmen  and  lingula),  there  was  a  trend  toward
a  higher  percentage  of  emphysema  in  the  right  upper  and
middle  lobes  compared  to  the  left  upper  lobe  (median
values:  0.08  versus  0.03;  P  =  0.055).
The  overall  percentage  of  emphysema  was  not  signiﬁ-
antly  different  between  smokers  (current  and  ex-smokers)
n  Gold  stage  0  (mean  percentage:  0.07%)  and  smokers  (cur-
ent  and  ex-smokers)  in  Gold  stage  1  (mean  percentage:
.54%)  (P  =  0.77).  Regarding  the  nonsmoker  subgroup,  a  sin-
le  subject  showed  CT  features  of  emphysema  which  was
ubsequently  quantiﬁed  (percentage  after  artefact  correc-
ion:  0.01%).  The  remaining  nonsmoker  subjects  without
isual  depiction  of  emphysema  did  not  undergo  quantitative
nalysis.
s.
h Current  smokers
with  emphysema
n  =  21
Ex-smokers  with
emphysema
n  = 8
P  value
0.47  ±  1.21  0.03  ±  0.03  0.1823
9]  0.05  [0—5.19]  0  [0—0.14]
0.32  ±  0.61  0.04  ±  0.  03  0.1528
6]  0.03  [0—2.16]  0  [0—0.15]
0.63  ±  1.90  0.03  ±  0.  02  0.2476
9]  0.03  [0—8.39]  0  [0—0.12]
 0.53  ±  0.97  0.08  ±  0.  06  0.3762
3]  0.08  [0—3.83]  0  [0—0.34]
0.70  ±  1.83  0.06  ±  0.  05  0.2917
1]  0.03  [0—7.01]  0  [0—0.23]
0.08  ±  0.23  0.01  ±  0.  01  0.0755
0.01  [0—1.05]  0  [0—0.04]
0.61  ±  1.08  0.09  ±  0.12  0.2119
8]  0.09  [0—3.88]  0.05  [0—0.34]
0.18  ±  0.59  0.01  ±  0.  01  0.1168
0  [0—2.71]  0  [0—0.05]
0.48  ±  2.02  0.01  ±  0.01  0.2083
0  [0—9.29]  0  [0—0.03]
smokers with emphysema were obtained using the Mann—Whitney
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elationship between the presence and
everity of emphysema with clinical
haracteristics and pulmonary function test
esults of smokers
resence  of  emphysema  on  lung  images
ompared  to  smokers  without  emphysema,  smokers  with
mphysema  had:
a  higher  median  value  of  tobacco  consumption  (30  vs  15.5
pack-years;  P  =  0.0005);
a lower  median  value  of  BMI  (24.24  kg/m2 vs  26.55  kg/m2;
P  =  0.0403),  independent  from  the  Gold  score.
A
e
e
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Table  4  Pulmonary  function  test  results  of  smokers  according
Smokers  without
emphysema  on  CT  images
n  =  46
FRC, L
mean  ±  SD  2.80  ±  0.64  
median,  range  2.80  [1.22—4.10]  
Peak  Expiratory  Flow,  L/s
mean  ±  SD  7.61  ±  1.85  
median,  range  7.18  [3.93—11.84]  
MEF  75,  L/s
mean  ±  SD  6.64  ±  1.81  
median,  range  6.80  [3.02—11.61]  
MEF  50,  L/s
mean  ±  SD  3.71  ±  1.15  
median,  range  3.70  [1.55—6.33]  
MEF  25,  L/s
mean  ±  SD  1.13  ±  0.47  
median,  range  1.02  [0.33—2.59]  
FEV1,L
mean  ±  SD  3.12  ±  0.73  
median,  range  3.19  [1.70—4.65]  
FEV1/FVC,  %
mean  ±  SD  76.55  ±  5.41  
median,  range  77  [64—89]  
TLCO,  mL/min/mm  Hg
mean  ±  SD  23.32  ±  5.21  
median,  range  22.89  [14.8—34.7]  
RV,  L
mean  ±  SD  1.89  ±  0,43  
median,  range  1.90  [0.95—2.84]  
TLC,  L
mean  ±  SD  5.98  ±  1.16  
median,  range  5.98  [3.25—8.42]  
SD: Standard deviation; FRC: Functional residual capacity; FVC: Forced
and 25% of FVC; FEV1: Forced expiratory volume in one second; VC:
Residual volume; TLC: Total lung capacity.
Statistical comparisons were obtained using the Mann—Whitney test. SK.  Yasunaga  et  al.
As  shown  in  Table  4,  smokers  with  emphysema  had  signif-
cantly  higher  mean  values  of  FRC  (P  =  0.0012),  RV  (<  0.0001)
nd  TLC  (P  =  0.0157)  than  smokers  without  emphysema  but
o  signiﬁcant  differences  were  found  in  the  mean  values
f  TLCO  nor  expiratory  ﬂows  (P  >  0.05)  between  the  two
ubgroups.
everity  of  emphysema  on  lung  images
 correlation  was  found  between  the  percentage  of
mphysema  and  the  number  of  pack-years  in  current  smok-
rs  (r  =  0.34215;  P  = 0.0330)  and  ex-smokers  (r  =  0.44104;
 =  0.0071).  As  shown  in  Table  5,  signiﬁcant  correlation  was
 to  the  presence  of  emphysema  on  CT  examinations.
Smokers  with  emphysema
on  CT  images
n  =  29
P value
3.42  ±  0.80  0.0012
3.40  [1.99—4.99]
7.80  ±  1.87  0.6167
7.51  [4.83—13.05]
6.66  ±  1.86  0.9740
6.43  [3—10.81]
3.61  ±  1.48  0.5104
3.15  [1.19—7.12]
1.11  ±  0.53  0.7195
0.88  [0.35—2.29]
3.26  ±  0.85  0.5790
3.14  [1.99—4.77]
75.46  ±  6.35  0.6435
76.47  [57.8—86.6]
22.78  ±  5.84  0.7318
21.50  [10.39—36.17]
2.36  ±  0.42  <  0.0001
2.33  [1.68—3.06]
6.67  ±  1.21  0.0157
6.52  [4.53—8.81]
 vital capacity; MEF 75,50,25: Maximal expiratory ﬂow at 75%50%
 Vital capacity; TLCO: Carbon monoxide diffusing capacity; RV:
igniﬁcant differences are underlined in bold characters.
Quantitative  CT  in  asymptomatic  smokers  
Table  5  Correlation  between  the  overall  percentage
of  emphysema  and  pulmonary  function  parameters  in
smokers.
Functional  data  Pearson  test
r P
FVC  0.233  0.0440
FEV1  —0.008  0.9439
FEV1/VC  —0.35227  0.0019
MMEF  —0.19889  0.0894
TLC  0.36599  0.0012
FRC  0.25831  0.0263
RV  0.31770  0.0055
TLCO  —0.34333  0.0026
FRC: Functional residual capacity; FVC: Forced vital capacity;
MMEF: Maximal mid expiratory ﬂow; FEV1: Forced expiratory
volume in one second; VC: Vital capacity; TLCO: Carbon
monoxide diffusing capacity; RV: Residual volume; TLC: Total
lung capacity. Correlations were established using absolute
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found  between  the  percentage  of  emphysema  and  TLC,  FRC,
RV  and  alteration  of  TLCO.
Discussion
In  this  study  characterized  by  relatively  young  asymptomatic
smokers  (between  34  and  59  years  old),  CT  detected  very
mild  forms  of  emphysema,  with  an  average  of  0.13%  of
lung  volume  affected  by  lung  destruction.  This  quantita-
tive  approach  fulﬁlled  all  speciﬁc  recommendations  in  terms
of  section  thickness,  radiation  dose,  attenuation  coefﬁ-
cient  threshold  and  kernel  of  reconstruction  for  objective
assessment  of  emphysema  on  CT  sections  [23—26]. Con-
versely  to  previous  studies  [15—17,27],  our  quantitative
analysis  was  undertaken  after  manual  exclusion  of  pseudo-
emphysematous  lesions.  Due  to  motion  or  beam-hardening
artifacts  at  the  interface  between  the  outer  lung  surface
and  chest  wall,  these  artifacts  are  usually  included  in
the  borderlands  of  normality  on  CT  examinations  [28—30].
Whereas  their  impact  on  quantitative  assessment  of  emphy-
sema  in  severely  diseased  lungs  is  likely  to  be  negligible,
their  exclusion  in  the  context  of  limited  lung  destruction
was  deemed  methodologically  relevant.  Our  quantitative
analysis  enabled  us  to  analyze  the  overall  percentage
of  emphysema  in  relationship  with  the  subjects’  smoking
habits.  Whereas  recent  studies  have  reported  a  rapid  fall
in  lung  density  in  the  two  years  after  smoking  cessation
[31,32],  we  did  not  ﬁnd  signiﬁcant  difference  in  the  over-
all  percentage  of  emphysema  between  current  smokers  and
ex-smokers.  Considering  that  the  ex-smokers  of  our  study
group  had  quitted  smoking  for  more  than  two  years,  our  ﬁnd-
ings  may  simply  reﬂect  morphologic  changes  devoid  of  the
above-mentioned  short-term  effects  of  changes  in  smoking
behaviour.
Despite  the  limited  extent  of  emphysema  in  our  popu-
lation,  quantitative  information  enabled  demonstration  of
links  between  structural  and  functional  changes.  Although
r
m
r
e615
he  presence  of  emphysema  was  not  found  to  be  associated
ith  airﬂow  limitation,  thus  conﬁrming  previous  reports
8,9,33—35], we  found  a  correlation  between  the  severity
f  lung  destruction  and  airway  obstruction.  This  ﬁnding  sug-
ests  that  the  established  contribution  of  emphysema  to
he  airﬂow  obstruction  observed  in  more  advanced  stages
f  COPD  can  also  be  depicted  in  mild  forms  of  emphy-
ema.  Regarding  the  relationship  between  emphysema  and
educed  carbon  monoxide  transfer,  we  found  no  association
etween  the  presence  of  emphysema  and  TLCO  alteration,
 ﬁnding  related  to  the  lack  of  sensitivity  of  TLCO  at  rest
o  detect  very  mild  emphysema  [36]. However,  the  percent-
ge  of  emphysema  was  negatively  correlated  with  reduced
arbon  monoxide  transfer,  reinforcing  the  well-established
inks  between  lung  destruction  and  reduction  of  gas  diffus-
ng  capacity  in  more  severe  disease  [37,38].  Unlike  other
uthors  [8,9],  we  found  relationships  between  the  presence
nd  severity  of  emphysema  and  lung  distension.  On  the  basis
f  these  results,  one  can  suggest  that  quantitative  CT  is  more
ensitive  than  visual  analysis  in  estimating  the  functional
amage  related  to  emphysema.
In  the  light  of  the  direct  relationships  currently  pointed
ut  between  emphysema  and  lung  cancer  [1—3],  we  investi-
ated  whether  there  might  be  differences  in  the  severity  of
mphysema  between  the  right  and  left  upper  lobes.  Consid-
ring  current  and  ex-smokers  with  emphysema  altogether,
e  observed  a  trend  toward  a  higher  median  percentage  of
mphysema  in  the  right  upper  and  middle  lobes  compared  to
he  left  upper  lobe  (i.e.,  culmen  and  lingula).  This  regional
peciﬁcity  of  emphysema  in  asymptomatic  smokers  is  worth
mphasizing  as  it  could  provide  additional  arguments  for
he  right  upper  lobe  predilection  of  lung  cancers.  Similarly
o  that  previously  reported  in  COPD  patients  [39—42],  we
bserved  that  smokers  with  emphysema  had  signiﬁcantly
ower  median  values  of  BMI  compared  to  smokers  without
mphysema.  Whereas  the  causal  pathway  between  emphy-
ema  and  decreased  BMI  remains  debated,  one  can  speculate
hat  the  systemic  inﬂammation  described  in  COPD  might  be
ufﬁciently  marked  in  asymptomatic  smokers  to  inﬂuence
heir  phenotype.  In  our  population,  it  was  also  interesting
o  observe  a  correlation  between  the  percentage  of  emphy-
ema  in  current  and  ex-smokers  and  tobacco  consumption,
 ﬁnding  previously  exclusively  described  in  symptomatic
OPD  patients  [5,14,43].
This  study  suffers  from  several  limitations.  Firstly,  our
ohort  included  a  limited  number  of  smokers  which  was
nherent  to  our  study  design,  restricted  to  volunteers
ecruited  at  the  time  of  their  annual  health-care  evalua-
ion  at  our  institution.  Secondly,  our  quantitative  estimation
f  emphysema  included  an  operator-dependent  manoeu-
re  aimed  at  excluding  pseudo-emphysematous  lesions,
unning  the  risk  of  misclassifying  truly  emphysematous
esions  as  artifacts.  This  potential  drawback  was  limited
y  the  consensus  reading  of  lung  images  which  was  also
pplied  for  artifact  selection.  Moreover,  most  motion  arti-
acts  were  present  in  the  lower  lung  zones  at  the  level  of
hich  tobacco-smoke  lesions  are  not  predominantly  located.
hirdly,  we  provided  information  on  the  percentage  of  inspi-
atory  emphysematous  lung  volume  but  did  not  give  absolute
easurements  of  destructive  lung  changes.  This  would  have
equired  acquisition  of  datasets  with  spirometric  gating,  not
asily  applicable  in  routine  CT  examinations.  Lastly,  it  is
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ikely  that  the  percentage  of  emphysema  calculated  for  each
ubject  in  our  study  combined  hypoattenuating  areas  truly
inked  to  lung  destruction  with  emphysema-like  changes  that
an  also  be  recognized  in  young  healthy  nonsmokers,  pre-
umably  related  to  zones  of  hyperexpanded  distal  air  spaces
ithout  actual  loss  of  lung  tissue  [44—46].  The  absence
f  quantitative  analysis  in  subjects  without  morphological
hanges  of  emphysema  precluded  any  estimation  of  such
hanges  in  the  group  of  nonsmoker  subjects.
onclusion
n  conclusion,  this  study  is  the  ﬁrst  study  providing  quanti-
ative  analysis  of  emphysema  in  asymptomatic  smokers  on
xaminations  devoid  of  confounding  artifacts.  Quantitative
nformation  on  the  subclinical  parenchymal  lung  disease  can
e  correlated  to  pulmonary  functional  alterations.  These
ndings  suggest  a  broader  use  of  CT  in  the  evaluation  of
obacco-related  pulmonary  disease.
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ppendix I.
mage  data  sets,  consisting  of  contiguous  1-mm  thick  inspi-
atory  lung  CT  scans,  reconstructed  with  a  soft  kernel  (B20),
ere  sent  to  a  research  workstation  (Syngo  MMWP  version
007-A,  Siemens  Forchheim,  Germany)  running  MevisPulmo
oftware,  version  3.0  (MeVis  Bremen,  Germany).  Automated
obar  quantiﬁcation  of  emphysema  consisted  of  a  6-step  pro-
ess,  modiﬁed  from  Revel  et  al.  [47].
Segmentation  of  the  overall  airspace  by  applying  an  upper
threshold  of  -400  HU,  followed  by  an  automated  segmen-
tation  of  the  tracheobronchial  tree  up  to  the  segmental
level.
Lobar  segmentation  allowing  automated  delineation  of
each  of  the  ﬁve  pulmonary  lobes.  A  colored  mask  was
superimposed  on  the  CT  images,  with  a  different  color  for
each  lobe.  By  scrolling  through  the  multiplanar  images,
it  was  possible  to  evaluate  if  the  automated  lobar  seg-
mentation  was  adequate.  If  necessary  it  was  possible
to  correct  manually  the  lobar  limits  displayed  by  the
software.
Low  attenuation  area  (LAA)  segmentation  using  an  upper
threshold  of  -960  HU.
Initial  display  of  quantiﬁcation  results:  at  this  step,  the
percentage  of  hypoattenuated  areas  indicated  by  the
MevisPulmo  software  included  not  only  emphysema  but
also  artifacts  mimicking  emphysematous  lesions  (respi-
ratory  and  cardiogenic  motion  artifacts;  beam-hardening
artifacts  at  the  interface  between  the  lung  parenchyma
and  chest  wall).
Artifact  removal  using  a  dedicated  application.
Final  display  of  quantiﬁcation  results  in  a  table  indicating
for  the  whole  lung,  the  right  and  left  lung  and  each  of  ﬁve
[K.  Yasunaga  et  al.
lobes,  the  absolute  and  relative  volume  as  well  as  the  LAA
proportion  representing  the  emphysema  score.
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